Centene (NYSE:CNC – Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 7.250- for the period, compared to the consensus earnings per share estimate of 7.300. The company issued revenue guidance of -.
Analyst Upgrades and Downgrades
CNC has been the subject of several recent research reports. Robert W. Baird reduced their price target on Centene from $71.00 to $69.00 and set a “neutral” rating for the company in a research report on Tuesday, April 15th. Barclays cut their price objective on Centene from $93.00 to $84.00 and set an “overweight” rating for the company in a report on Monday, April 28th. Jefferies Financial Group dropped their target price on Centene from $64.00 to $61.00 and set a “hold” rating for the company in a report on Tuesday, April 29th. Argus cut Centene from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. Finally, Guggenheim reaffirmed a “neutral” rating on shares of Centene in a research report on Tuesday, April 29th. Seven analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $79.77.
Centene Stock Up 1.0%
Centene (NYSE:CNC – Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $2.90 EPS for the quarter, topping the consensus estimate of $2.52 by $0.38. Centene had a return on equity of 13.85% and a net margin of 2.03%. The company had revenue of $46.62 billion during the quarter, compared to analyst estimates of $43.16 billion. During the same quarter in the previous year, the company posted $2.26 earnings per share. Centene’s revenue was up 15.4% compared to the same quarter last year. Equities analysts predict that Centene will post 6.86 EPS for the current fiscal year.
About Centene
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Read More
- Five stocks we like better than Centene
- Dividend Capture Strategy: What You Need to Know
- Homebuilders: Oversold, Undervalued, and Ready to Run?
- Bank Stocks – Best Bank Stocks to Invest In
- SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- AMD’s AI-Powered Stock Price Rally Just Shifted Gears
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.